Insmed, Inc.

INSM Healthcare Biotechnology

Insmed, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $606.4 million, up 66.7% from fiscal 2024.

Revenue
+268.4%
EPS
+73.8%
Free cash flow
+81.1%
Total debt
+0.27%

Quarter to September 2026, against a year earlier

112.32 3.56 +3.27%
Market cap
$23.9B
P/E
0.0×
Fwd P/E
−64.6×
Dividend yield
—
F-score
4/9
Altman Z
9.29
Beneish M
−1.90
Dividend safety
n/a

Insmed, Inc. (INSM) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Insmed, Inc. (INSM) trades at a EV/FCF of −37.2×. Over the past ten years it has ranged from −48.4× (December 2025) to −2.6× (December 2018); the current reading is higher than 2% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 −35.1× —
FY2024 −15.9× —
FY2023 −8.4× —
FY2022 −5.8× —
FY2021 −7.9× —
FY2020 −13.7× —
FY2019 −6.5× —
FY2018 −3.1× —

Quarterly newest first

Period EV/FCF Change
Sep 2026 −39.2× —
Jun 2026 −28.2× —
Mar 2026 −37.8× —
Dec 2025 −35.1× —
27 more quarters

Against its own ten years

Low −48.4× High −2.6×
Ten-year median −8.1×
Current reading's percentile 2

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on INSM